Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome
Authors:
- 26 February 2009
- journal article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 24 (6) , 1330-1338
Abstract
BACKGROUND First trimester screening (FTS) for Down syndrome combines measurement of nuchal translucency, free beta-human chorionic gonadotrophin and pregnancy-associated plasma protein-A (PAPP-A). The aim of this study was to undertake a detailed analysis of FTS results in singleton pregnancies conceived using assisted reproductive technologies (ART) and non-ART pregnancies.Keywords
This publication has 44 references indexed in Scilit:
- First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10–14 weeks of gestationFertility and Sterility, 2008
- Neonatal outcome of 937 children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cyclesHuman Reproduction, 2008
- Use of the combined first‐trimester screen result and low PAPP‐A to predict risk of adverse fetal outcomesPrenatal Diagnosis, 2008
- First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproductionHuman Reproduction, 2005
- First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)American Journal of Obstetrics and Gynecology, 2004
- Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screeningPrenatal Diagnosis, 2004
- Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal developmentDevelopment, 2004
- Prenatal Diagnosis after ART Success: The Role of Early Combined Screening Tests in Counselling Pregnant PatientsPlacenta, 2003
- Serum triple-marker screening in in vitro fertilization and naturally conceived pregnanciesObstetrics & Gynecology, 1997
- DOWN'S SYNDROME SCREENING MARKER LEVELS FOLLOWING ASSISTED REPRODUCTIONPrenatal Diagnosis, 1996